UK MHRA is reviewing license application for Novo Nordisk's (NOVOB DC) oral Semaglutide 25mg, expects to announce decision before year-end

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Mexico to sell USD-denominated 2034, 2038, 2056 debt

Brazil's natural gas production 182.57mln bcm/day in November, +15.7% Y/Y, via ANP; Brazil's oil output 3.77mln bpd, +14% Y/Y

UK MHRA is reviewing license application for Novo Nordisk's (NOVOB DC) oral Semaglutide 25mg, expects to announce decision before year-end

US PRE-MARKET MOVERS: Mag-7, TSM, QXO, MBLY, HAL/CVX/XOM, DUOL

Incyte (INCY) announces positive topline results from pivotal study of Tafasitamab as a first-line treatment for diffuse large B-cell lymphoma

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free